Answers are grounded in this paper and cite their sources.
The PI3K protein is involved in the PI3K/AKT/mTOR pathway. Deregulation of this pathway through PIK3CA mutation is common in various tumors. The aim of this work is to identify hotspot mutation at exons 9 and 20 in Tunisian patients with sporadic or hereditary breast cancer.
No takes yet. Share an insight, caveat, or question.
Debouki-Joudi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: